Yong Oh Lee

Title: Yong Oh Lee: Innovator in Cardioprotective Pharmaceutical Compositions

Introduction

Yong Oh Lee is a prominent inventor based in Koyang-si, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that offer cardioprotective effects. His work focuses on innovative solutions for treating ischemic heart diseases and cerebrovascular conditions.

Latest Patents

Yong Oh Lee holds a patent for "Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same." This invention relates to benzothiophen-2-carbonylguanidine derivatives, which exhibit a potent inhibitory effect on the sodium/hydrogen exchanger NHE-I. These derivatives have been shown to improve functional recovery from ischemia/reperfusion-induced heart injury in isolated ischemic heart models. Additionally, they significantly reduce myocardial infarct size in in vivo ischemic animal models, demonstrating excellent cardioprotective effects. The derivatives also protect neuronal cells and the brain, reducing cerebral infarct sizes in in vivo ischemic brain models. This innovation can be effectively utilized for the prevention and treatment of ischemic heart diseases, such as myocardial infarction, arrhythmia, and angina pectoris, as well as cerebrovascular diseases like cerebral stroke.

Career Highlights

Yong Oh Lee is affiliated with the Korea Research Institute of Chemical Technology, where he continues to advance his research in pharmaceutical compositions. His work has garnered attention for its potential impact on treating serious health conditions, making him a valuable asset in the field of medical research.

Collaborations

He has collaborated with notable colleagues, including Kyu Yang Yi and SunKyung Lee, contributing to the advancement of innovative pharmaceutical solutions.

Conclusion

Yong Oh Lee's contributions to the field of pharmaceuticals, particularly through his patented innovations, highlight his commitment to improving health outcomes for patients suffering from ischemic heart and cerebrovascular diseases. His work exemplifies the importance of innovation in medical research and its potential to save lives.